Anzeige
+++– 421.670 CAD an Käufen, während Silber $88 erreicht Insider kaufen kräftig zu – 421.670 CAD an Käufen, während Silber $88 erreicht+++
Original-Research

Nabaltec AG (von NuWays AG): BUY 09.02.2026, 09:00 Uhr von dpa-AFX Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
Nabaltec 10,55 EUR +0,24 % Lang & Schwarz

^

Original-Research: Nabaltec AG - from NuWays AG

09.02.2026 / 09:00 CET/CEST

Dissemination of a Research, transmitted by EQS News - a service of EQS

Group.

The issuer is solely responsible for the content of this research. The

result of this research does not constitute investment advice or an

invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of NuWays AG to Nabaltec AG

Company Name: Nabaltec AG

ISIN: DE000A0KPPR7

Reason for the research: Update

Recommendation: BUY

from: 09.02.2026

Target price: EUR 18.00

Target price on sight of: 12 months

Last rating change:

Analyst: Christian Sandherr

Unjustified valuation disconnect;BUY

Despite challenging industry conditions that have pushed several larger

peers close to breakeven, Nabaltec continues to deliver resilient margins

and robust operating cash flows. At the same time, the company now boasts a

significantly strengthened balance sheet. Nevertheless, the shares are

trading at their lowest level in over a decade, a valuation disconnect that

we believe is unwarranted.

Q4 to put NTG in the mid-points of the FY25 margin guidance. With Q4 sales

showing similar trajectory as the first three quarters (9M -2.4% yoy), the

expected EUR 44.4m sales (eNuW) are to put NTG at the lower end of the FY

sales guidance (1-2% yoy sales decline). Importantly, despite an expected

margin of only 4.3%, NTG should meet the guidance mid-point of 8%. With

this, the company outperforms most of its listed chemical peers, which are

around the break-even point (e.g. Lanxess, and Wacker Chemie).

FY26 to return to growth. For the current year, we expect Nabaltec to return

to mid single-digit sales growth (5.6%) despite some pricing headwinds

compensated for by higher volumes. Most importantly, demand for ground

hydroxides (ATH) is seen to remain robust thanks to several secular trends

(AI being one of them). At the same time, further volume increases of

viscosity optimized hydroxides should overcompensate for the still weak

boehmite demand. Next to boehmites, Specialty Alumina is likely to continue

moving sideways. Margins to remain well, under continued challenging

circumstances; eNuW 8.3% EBIT margin.

Current capex program coming to an end. In FY25e, NTG should have spend some

EUR 25m on capex, slightly below our old EUR 32m estimate due to some

postponements. With this, FY26e capex is seen at EUR 30m (eNuW), returning to

a sustainable level of EUR 15m p.a. thereafter. With this, all major

maintenance investments as well as the production capacity expansions for

viscosity-optimized hydroxides and boehmite should be finalized, enabling

potential group sales of up to EUR 300m. Importantly, even if boehmite demand

does not recover as quickly as anticipated, the additional capacity can be

flexibly utilized by shifting production toward ATH.

Valuation remains compelling. The shares continue to trade at a significant

37% discount to book value, despite the company navigating the current

market environment effectively. Notably, the last time Nabaltec traded below

book value, the company was highly leveraged and struggling with margins (EUR

4-5m EBIT with more than EUR 50m net debt), a strong contrast to today's much

stronger financial position (close to no net debt). Over the past five years

(incl. 2025e), Nabaltec has generated EUR 141m in operating cash flow,

underpinning solid cash conversion. Accordingly, adjusted free cash flow

yield (maintenance capex only) is an attractive 14.8% in FY25e.

We hence confirm our BUY rating with an unchanged EUR 18 PT, which is based on

a blended FY25/26e FCFY approach.

You can download the research here:

https://eqs-cockpit.com/c/fncls.ssp?u=2424bce39ec8a53a27240dabd3fb1b36

For additional information visit our website:

https://www.nuways-ag.com/research-feed

Contact for questions:

NuWays AG - Equity Research

Web: www.nuways-ag.com

Email: research@nuways-ag.com

LinkedIn: https://www.linkedin.com/company/nuwaysag

Adresse: Mittelweg 16-17, 20148 Hamburg, Germany

++++++++++

Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss

bestimmter Börsengeschäfte.

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben

analysierten Unternehmen befinden sich in der vollständigen Analyse.

++++++++++

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

View original content:

https://eqs-news.com/?origin_id=23241f9d-0589-11f1-8534-027f3c38b923&lang=en

---------------------------------------------------------------------------

2273026 09.02.2026 CET/CEST

°

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer